HLA Sensitization Following Major Cortical Allograft Bone Procedures
NCT00160719 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2012-10-30
Summary
The purpose of this study is to find out whether or not antibodies to the donor bone are present in the blood of patients who receive the donor bone.
Conditions
- Bone Cancer
Interventions
- PROCEDURE
-
retrieve blood samples
blood samples obtain pre-op, 6 and 12 months post-op
Sponsors & Collaborators
-
University of Florida
lead OTHER
Principal Investigators
-
Mark T. Scarborough, M.D. · University of Florida
Eligibility
- Min Age
- 12 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-09-30
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- United States
Study Locations
More Related Trials
-
The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT
NCT06362967 ·Status: RECRUITING ·Phase: PHASE2
-
Screening for Subjects to Participate in Studies of Blood Disorders
NCT00695123 ·Status: COMPLETED
-
Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
NCT06395220 ·Status: COMPLETED
-
Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
NCT02035189 ·Status: COMPLETED
-
Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes
NCT00001627 ·Status: COMPLETED
-
The Polarization and Expression of Chemokine Receptors of T Help Cell in the Pathogenesis of Acute and Chronic GVHD
NCT00207922 ·Status: UNKNOWN
-
UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT Survivors
NCT03377010 ·Status: COMPLETED
-
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
NCT01206309 ·Status: COMPLETED
-
NGS for HLA Typing of Donors and récipients oh Hematopoietic Stem Cells
NCT02892292 ·Status: COMPLETED
-
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
NCT00900055 ·Status: COMPLETED
-
Follow-up of Bone Quality in Long-Term Bone Marrow Transplant Survivors
NCT00594295 ·Status: COMPLETED
-
Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
NCT06450353 ·Status: RECRUITING
-
Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT00450268 ·Status: UNKNOWN
-
Activity Levels in Bone Marrow Transplant Patients
NCT04115241 ·Status: RECRUITING
-
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
NCT07235501 ·Status: NOT_YET_RECRUITING
-
The Role of CK18F in Predicting Graft-Versus-Host Disease (GvHD)
NCT00935324 ·Status: UNKNOWN
-
DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors
NCT04888286 ·Status: COMPLETED
-
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
NCT03541889 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
NCT02305979 ·Status: COMPLETED
-
Pre-Exercise for Allogeneic Stem Cell Transplant Patients
NCT03080792 ·Status: TERMINATED ·Phase: NA
-
UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
NCT00578045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluation, Treatment, and Training for Patients With Blood Disorders
NCT00001397 ·Status: COMPLETED
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)
NCT01675102 ·Status: COMPLETED
-
Bone Marrow Grafting for Leukemia and Lymphoma
NCT00186147 ·Status: ENROLLING_BY_INVITATION